Illicit drug use by pregnant women in metropolitan, medium sized, and rural counties using meconium sampling

Hl, Brown; Hiett, AK; Gath, SF

doi:10.1016/s0002-9378(97)80492-9

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, these considerations only concern postnatal care. Unfortunately, no current cost estimations for short- and long-term costs for intrauterinally exposed children are available, but Brown et al already estimated the necessary lifetime treatment costs of in utero substance-exposed infants (alcohol, tobacco and other drugs) in the USA of approximately $750,000–1,400,000 [50], giving an idea of the scope of the economic burden. Therefore, it is even more important to provide adequate maternal and neonatal treatment for this special patient population.…”

Section: Economic Considerationsmentioning

confidence: 99%

Should pregnant women with substance use disorders be managed differently?

Metz¹,

Köchl²,

Fischer³

2012

Neuropsychiatry

View full text Add to dashboard Cite

Summary Pregnant women with substance use disorders have multiple special needs, which might be best managed within a multiprofessional treatment setting involving medical, psychological and social care. Adequate treatment provision remains a challenge for healthcare professionals, who should undergo special training and education when working with this patient population. Careful assessment and screening is necessary to tailor interventions individually to the woman's needs in order to achieve beneficial clinical outcomes for mothers and newborns, whereas the choice of treatment options highly depends on the type of substance of abuse and evidence-based treatment interventions available. Economic considerations have shown that early multiprofessional treatment might yield better clinical outcomes and save healthcare costs over the lifespan.

show abstract

Section: Economic Considerationsmentioning

confidence: 99%